Gemeinschaftspraxis Dr. Kronawitter/Dr. Jung
- Address
- Schierghoferstraße 1, 83278 Traunstein, Germany
Gemeinschaftspraxis Dr. Kronawitter/Dr. Jung - Advanced Breast Cancer Research
Gemeinschaftspraxis Dr. Kronawitter/Dr. Jung is a specialized clinical research practice dedicated to advancing treatment options for patients with breast cancer. The center focuses on innovative therapeutic approaches, particularly in high-risk and aggressive breast cancer subtypes where improved treatment strategies are critically needed.
- Triple-negative breast cancer immunotherapy and neoadjuvant chemotherapy combinations
- HER2-negative breast cancer with high relapse risk following standard treatment
- Novel antibody-drug conjugates and immune checkpoint inhibitors in early-stage disease
The practice participates in pivotal Phase III clinical trials investigating atezolizumab immunotherapy combined with chemotherapy in triple-negative breast cancer, as well as studies evaluating sacituzumab govitecan for patients with HER2-negative disease at high risk of relapse. These studies aim to improve event-free survival and invasive disease-free survival outcomes, representing cutting-edge approaches to managing aggressive breast cancer phenotypes that historically have limited treatment options.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Gemeinschaftspraxis Dr. Kronawitter/Dr. Jung
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase III Evaluation of Sacituzumab Govitecan Versus Physician's Choice in HER2-Negative Breast Cancer with High Relapse Risk Post-Neoadjuvant Therapy | GBG Forschungs GmbH | Phase III | Not Recruiting | Oct 2020 | — |
IMP list
lock Showing 1 of 10 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Carboplatin | 2 | Unknown | 2018-06-13 | 2020-10-23 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.